Razak, Albiruni R. Abdul
Wang, Hung-Ming
Chang, Jang-Yang
Ahn, Myung-Ju
Munster, Pamela
Blumenschein, George Jr
Solomon, Benjamin
Lim, Darren Wan-Teck
Hong, Ruey-Long
Pfister, David
Saba, Nabil F.
Lee, Se-Hoon
van Herpen, Carla
Quadt, Cornelia
Bootle, Douglas
Blumenstein, Lars
Demanse, David
Delord, Jean-Pierre
Funding for this research was provided by:
Novartis Pharma AG
Article History
Accepted: 31 August 2023
First Online: 25 October 2023
Declarations
:
: This work was supported by Novartis Pharmaceuticals AG.
: Dr. Abdul Razak reports grants from Novartis, during the conduct of the study. Dr. Wang has nothing to disclose. Dr. Chang has nothing to disclose. Dr. Ahn has nothing to disclose. Dr. Munster has nothing to disclose. Dr. Blumenschein, Jr reports personal fees from Abbvie, personal fees from Adicet, personal fees from Amgen, personal fees from Ariad, grants and personal fees from Bayer, personal fees from Clovis Oncology, grants from Adaptimmune, grants from Elelixis, grants from GlaxoSmithKline, grants from Immatics, grants from Immunocore, grants from Incyte, grants from Kite Pharma, grants from Macrogenics, grants from Torque, grants and personal fees from AstraZenaca, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Celgene, grants and personal fees from Genetech, grants and personal fees from MedImmune, grants and personal fees from Merck, grants and personal fees from Novartis, grants and personal fees from Roche, grants and personal fees from Xcovery, personal fees from Virogin Biotech, personal fees from Johnson & Johnson/Janssen, personal fees from Maverick Therapeutics, outside the submitted work. Dr. Solomon has nothing to disclose. Dr. Lim has nothing to disclose. Dr. Hong has nothing to disclose. Dr. Pfister reports grants and non-financial support from Novartis, during the conduct of the study; personal fees from Boehringer Ingelheim, outside the submitted work. Dr. Saba reports grants and personal fees from Merck, GSK, BMS and Rakuten, outside the submitted work. Dr. Lee reports personal fees from AstraZeneca/MedImmune, personal fees from Roche, grants and personal fees from Merck, personal fees from Novartis, outside the submitted work. Dr. van Herpen has nothing to disclose. Dr. Quadt is a paid employee of Novartis Pharma AG (Study Sponsor). Dr. Bootle is a paid employee of Novartis Pharma AG (Study Sponsor). Dr. Blumenstein is a paid employee Novartis Institute for Biomedical Research (Study Sponsor). Demanse paid employee of Novartis Pharma AG (Study Sponsor). Dr. Delord has nothing to disclose.
: ARA-R, CQ, DB and DD developed the study design. DD collected data. All authors critically reviewed and approved final draft and are accountable for accuracy and integrity.
: The datasets that support the findings of this study are available from the corresponding (Dr Razak) upon reasonable request.
: Independent Review Board / Ethics Committee reviewed and approved all study materials prior to initiating patient recruitment and data collection at the participating Institutions.
: Written Informed Consent was obtained from all study participants prior to initiation any study activities.
: All authors provided consent for publication.